NCT02255123
已完成
不适用
A Retrospective Multicenter Study to Determine 4-Year Clinical Outcomes in Subjects Previously Enrolled in the CTOT-05 Study (CTOT-18)
概览
- 阶段
- 不适用
- 干预措施
- 未指定
- 疾病 / 适应症
- Cardiac Transplantation
- 发起方
- National Institute of Allergy and Infectious Diseases (NIAID)
- 入组人数
- 178
- 试验地点
- 12
- 主要终点
- Composite incidence of Death, Re-transplantation or re-listed for transplantation, Coronary stent, Myocardial Infarction and Clinical evidence of CAV per ISHLT grading
- 状态
- 已完成
- 最后更新
- 10年前
概览
简要总结
This study is a multicenter, non-randomized, retrospective study to collect long term (4 years post-transplant) clinical outcome data on subjects previously enrolled in the CTOT-05 study (NCT00466804) to evaluate participant and graft survival.
研究者
入排标准
入选标准
- •Subjects previously enrolled in the CTOT-05 study
- •Subjects 4 years post-transplant (+/- 6 months).
排除标准
- •Withdrawal of consent from the CTOT-05 study.
结局指标
主要结局
Composite incidence of Death, Re-transplantation or re-listed for transplantation, Coronary stent, Myocardial Infarction and Clinical evidence of CAV per ISHLT grading
时间窗: 48 months (+/- 6 months) after primary transplantation
Coronary Artery Vasculopathy (CAV) International Society for Heart and Lung Transplantation Registry (ISHLT)
次要结局
- Incidence of clinical evidence of CAV per ISHLT grading(48 months (+/- 6 months) after primary transplantation)
- Incidence of death(48 months (+/- 6 months) after primary transplantation)
- Incidence of re-transplantation or re-listed for transplantation(48 months (+/- 6 months) after primary transplantation)
- Incidence of myocardial infarction(48 months (+/- 6 months) after primary transplantation)
- Incidence of coronary stent(48 months (+/- 6 months) after primary transplantation)
研究点 (12)
Loading locations...
相似试验
已完成
不适用
A Retrospective Multicenter Study to Determine 5-Year Clinical Outcomes in Subjects Previously Enrolled in the CTOT-01 StudyKidney DiseaseKidney FailureEnd Stage Renal DiseaseNCT01974999National Institute of Allergy and Infectious Diseases (NIAID)184
终止
不适用
Controlled High Risk AVONEX® Multiple Sclerosis Prevention Study In Ongoing Neurological SurveillanceMultiple SclerosisNCT01156298Biogen383
已完成
不适用
Osilodrostat for the Treatment of Non-Cushing's Disease Cushing's SyndromeCushing's SyndromeNCT05633953RECORDATI GROUP103
已完成
不适用
Study of management of preterm labor in IndiaHealth Condition 1: null- Preterm LaborCTRI/2017/04/008307Abbott India Limited285
已完成
不适用
Retrospective Study in a NSCLC M+ pEGFR Mutated Non-small Cell Lung Cancer PatientsNCT01795352AstraZeneca187